Conmed
(NYSE: CNMD)
announced that it promoted Patrick Beyer to the newly created role of COO.
Beyer previously served as president of international and global orthopedics at the Largo, Florida-based company. In his new role, his responsibilities include leading commercial businesses, plus operations, distribution, regulatory/quality and customer excellence.
“Pat has been invaluable in driving Conmed’s above-market growth and expanding our presence in key markets,” said Curt R. Hartman, Conmed chair, president, and CEO. “He is an experienced leader with a proven track record of commercial and operational excellence and delivering results, and I look forward to Pat’s continued impact on the organization.”
Beyer joined Conmed in 2014 as president of international. In October 2020, he received a promotion to the role of president of international and global orthopedics. He served in that post for nearly four years before this latest promotion.
As president of international and global orthopedics, Beyer took on added responsibilities for global orthopedics R&D and U.S. orthopedics commercial business. He oversaw significant milestones at Conmed, including the acquisitions of In2Bones and BioRez.
Before Conmed, Beyer spent 21 years at Stryker in increasing roles of responsibility. He also served as CEO of ICNet International for four years.
“I am excited to take on this important leadership role at Conmed and to continue contributing to the company’s innovation and success,” Beyer said. “I look forward to continuing to work with the team to build on Conmed’s legacy of delivering high-quality products and creating value for physicians and patients around the world.”
